Stock 8037 CHINA BIOTECH SERVICES HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights China Biotech Services Holdings Limited

Equities

8037

BMG2152F1014

Delayed Hong Kong S.E.
Other stock markets
 08:04:56 14/05/2024 am IST 		5-day change 1st Jan Change
0.375 HKD +1.35% Intraday chart for China Biotech Services Holdings Limited +25.42% -51.95%
28/03 China Biotech Services Holdings Limited Announces Not Recommends Final Dividend for the Year Ended 31 December 2023 CI
28/03 China Biotech Services Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
China Biotech Services Holdings Limited Announces Not Recommends Final Dividend for the Year Ended 31 December 2023
CI
China Biotech Services Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
China Biotech Services Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023
CI
Pengbo Medical Technology Co., Ltd. Announces the Approval by the Hainan Provincial Medical Products Administration for the Import of Medical Devices
CI
China Biotech Services Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
China Biotech Services Holdings Limited Provides Group Earnings Guidance for the Nine Months Ended September 30, 2023
CI
China Biotech Services Holdings Limited Announces Strategic Cooperation Framework Agreement with Astrazeneca Investment Co., Ltd
CI
China Biotech Services Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
China Biotech Services Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023
CI
China Biotech Services Holdings Limited Declares Final Dividend for the Year Ended 31 December 2022
CI
China Biotech Services Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
China Biotech Services Holdings Limited and The Chinese University of Hong Kong Enter into Memorandum of Understanding
CI
China Biotech Services Holdings Limited Provides Group Earnings Guidance for the Three Months Ended 31 March 2023
CI
China Biotech Services Holdings Limited Proposes Final Ordinary Dividend for the Year Ended December 31, 2022, Payable on 15 June 2023
CI
China Biotech Services Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2022
CI
China Biotech Services Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
China Biotech Services Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Nine Months Ended 30 September 2022
CI
China Biotech Services Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
China Biotech Services Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ending 30 June 2022
CI
China Biotech Services Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 8037 Stock
  4. News China Biotech Services Holdings Limited
  5. Highlights
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW